714
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Swarm Intelligence-Based Feature Selection for Amphetamine-Type Stimulants (ATS) Drug 3D Molecular Structure Classification

, &
Pages 914-932 | Received 15 May 2021, Accepted 06 Aug 2021, Published online: 20 Aug 2021
 

ABSTRACT

Swarm intelligence-based feature selection techniques are implemented by this work to increase classifier performance in classifying Amphetamine-type Stimulants (ATS) drugs. A recently proposed 3D Exact Legendre Moment Invariants (3D-ELMI) molecular descriptors as 3D molecular structure representational for ATS drugs. These descriptors are utilized as the dataset in this study. However, a large number of descriptors may cause performance degradation in the classifier. To complement this issue, this research applies three swarm algorithms with k-Nearest Neighbor (k-NN) classifier in the wrapper feature selection technique to ensure only relevant descriptors are selected for the ATS drug classification task. For this purpose, the binary version of swarm algorithms facilitated with the S-shaped or sigmoid transfer function known as binary whale optimization algorithm (BWOA), binary particle swarm optimization algorithm (BPSO), and new binary manta-ray foraging optimization algorithm (BMRFO) are developed for feature selection. Their performance is evaluated and compared based on seven performance criteria. Furthermore, the optimal feature subset was then evaluated with seven different classifiers. Findings from this study have revealed the dominance of BWOA by obtaining the highest classification accuracy with the small feature size.

Acknowledgments

This work was supported by Fundamental Research Grant Scheme [FRGS/1/2020/FTMK-CACT/F00461] from the Ministry of Higher Education, Malaysia.

Disclosure statement

The authors do not have any conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.